Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP182690.RAnt3-sOUOiIeLuJQb-buGmlrOmuvma__HmSgZsVFDexM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP182690.RAnt3-sOUOiIeLuJQb-buGmlrOmuvma__HmSgZsVFDexM130_assertion type Assertion NP182690.RAnt3-sOUOiIeLuJQb-buGmlrOmuvma__HmSgZsVFDexM130_head.
- NP182690.RAnt3-sOUOiIeLuJQb-buGmlrOmuvma__HmSgZsVFDexM130_assertion description "[TGF-beta1 inhibited IFN-gamma and TNF-alpha-induced TARC production in HaCaT cells via Smad2/3/of TGF-beta/Smad signaling pathway may be beneficial for treatment of atopic dermatitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP182690.RAnt3-sOUOiIeLuJQb-buGmlrOmuvma__HmSgZsVFDexM130_provenance.
- NP182690.RAnt3-sOUOiIeLuJQb-buGmlrOmuvma__HmSgZsVFDexM130_assertion evidence source_evidence_literature NP182690.RAnt3-sOUOiIeLuJQb-buGmlrOmuvma__HmSgZsVFDexM130_provenance.
- NP182690.RAnt3-sOUOiIeLuJQb-buGmlrOmuvma__HmSgZsVFDexM130_assertion SIO_000772 12615364 NP182690.RAnt3-sOUOiIeLuJQb-buGmlrOmuvma__HmSgZsVFDexM130_provenance.
- NP182690.RAnt3-sOUOiIeLuJQb-buGmlrOmuvma__HmSgZsVFDexM130_assertion wasDerivedFrom lhgdn-20090331 NP182690.RAnt3-sOUOiIeLuJQb-buGmlrOmuvma__HmSgZsVFDexM130_provenance.
- NP182690.RAnt3-sOUOiIeLuJQb-buGmlrOmuvma__HmSgZsVFDexM130_assertion wasGeneratedBy ECO_0000203 NP182690.RAnt3-sOUOiIeLuJQb-buGmlrOmuvma__HmSgZsVFDexM130_provenance.